Global Pertussis Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Pertussis Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pertussis Vaccine segment by Company

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Pertussis Vaccine segment by Type

Whole-cell Vaccines
Acellular Vaccines
Pertussis Vaccine segment by Application

12 Months Below
12 Months Above
Pertussis Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Pertussis Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pertussis Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pertussis Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Pertussis Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pertussis Vaccine industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pertussis Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Sales Value (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Volume (2019-2030)
1.2.3 Global Pertussis Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Pertussis Vaccine Market Dynamics
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 Pertussis Vaccine Market by Company
3.1 Global Pertussis Vaccine Company Revenue Ranking in 2023
3.2 Global Pertussis Vaccine Revenue by Company (2019-2024)
3.3 Global Pertussis Vaccine Sales Volume by Company (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Company (2019-2024)
3.5 Global Pertussis Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Pertussis Vaccine Company Manufacturing Base & Headquarters
3.7 Global Pertussis Vaccine Company, Product Type & Application
3.8 Global Pertussis Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Pertussis Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Pertussis Vaccine Market by Type
4.1 Pertussis Vaccine Type Introduction
4.1.1 Whole-cell Vaccines
4.1.2 Acellular Vaccines
4.2 Global Pertussis Vaccine Sales Volume by Type
4.2.1 Global Pertussis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pertussis Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Pertussis Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Pertussis Vaccine Sales Value by Type
4.3.1 Global Pertussis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pertussis Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Pertussis Vaccine Sales Value Share by Type (2019-2030)
5 Pertussis Vaccine Market by Application
5.1 Pertussis Vaccine Application Introduction
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Sales Volume by Application
5.2.1 Global Pertussis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Pertussis Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Pertussis Vaccine Sales Value by Application
5.3.1 Global Pertussis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pertussis Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Pertussis Vaccine Sales Value Share by Application (2019-2030)
6 Pertussis Vaccine Market by Region
6.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pertussis Vaccine Sales by Region (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
6.2.2 Global Pertussis Vaccine Sales by Region (2025-2030)
6.3 Global Pertussis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Pertussis Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Pertussis Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Pertussis Vaccine Sales Value by Region (2025-2030)
6.5 Global Pertussis Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Pertussis Vaccine Sales Value (2019-2030)
6.6.2 North America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Pertussis Vaccine Sales Value (2019-2030)
6.7.2 Europe Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pertussis Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Pertussis Vaccine Sales Value (2019-2030)
6.9.2 Latin America Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pertussis Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Pertussis Vaccine Sales Value Share by Country, 2023 VS 2030
7 Pertussis Vaccine Market by Country
7.1 Global Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Pertussis Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Pertussis Vaccine Sales by Country (2019-2030)
7.3.1 Global Pertussis Vaccine Sales by Country (2019-2024)
7.3.2 Global Pertussis Vaccine Sales by Country (2025-2030)
7.4 Global Pertussis Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Pertussis Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Pertussis Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Pertussis Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Pertussis Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Pertussis Vaccine Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Comapny Information
8.1.2 Sanofi Pasteur Business Overview
8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
8.1.5 Sanofi Pasteur Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Pertussis Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Mitsubishi Tanabe Pharma
8.3.1 Mitsubishi Tanabe Pharma Comapny Information
8.3.2 Mitsubishi Tanabe Pharma Business Overview
8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
8.3.5 Mitsubishi Tanabe Pharma Recent Developments
8.4 Wuhan Institute of Biological Products
8.4.1 Wuhan Institute of Biological Products Comapny Information
8.4.2 Wuhan Institute of Biological Products Business Overview
8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
8.4.5 Wuhan Institute of Biological Products Recent Developments
8.5 Walvax Biotechnology
8.5.1 Walvax Biotechnology Comapny Information
8.5.2 Walvax Biotechnology Business Overview
8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
8.5.5 Walvax Biotechnology Recent Developments
8.6 Minhai Biotechnology
8.6.1 Minhai Biotechnology Comapny Information
8.6.2 Minhai Biotechnology Business Overview
8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
8.6.5 Minhai Biotechnology Recent Developments
8.7 KM Biologics
8.7.1 KM Biologics Comapny Information
8.7.2 KM Biologics Business Overview
8.7.3 KM Biologics Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
8.7.5 KM Biologics Recent Developments
8.8 Chengdu Institute of Biological Products
8.8.1 Chengdu Institute of Biological Products Comapny Information
8.8.2 Chengdu Institute of Biological Products Business Overview
8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
8.8.5 Chengdu Institute of Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pertussis Vaccine Value Chain Analysis
9.1.1 Pertussis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pertussis Vaccine Sales Mode & Process
9.2 Pertussis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pertussis Vaccine Distributors
9.2.3 Pertussis Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings